Stocktoria

Curanex Pharmaceuticals Inc CURX

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-08-26

Curanex Pharmaceuticals Inc statistics & valuation

P / B0.7×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-36.5%-69.8%
Return on equity-37.7%-71.8%
Current ratio81.9335.54

Source: SEC EDGAR filings · CIK 0002025942 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.